https://www.londonstockexchange.com/exc ... K/13943004.
RNS Number : 7937N
GlaxoSmithKline PLC
22 January 2019
Issued: 22 January 2019, London UK - LSE Announcement
GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash consideration of approximately $5.1 billion (£4.0 billion). The transaction, which was announced on 3 December 2018, significantly strengthens GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.[url][url][/url][/url]